A comparative study of surgical and medical procedures: 932 pregnancy terminations up to 63 days gestation

被引:39
作者
Child, TJ [1 ]
Thomas, J [1 ]
Rees, M [1 ]
MacKenzie, IZ [1 ]
机构
[1] John Radcliffe Hosp, Dept Obstet & Gynaecol, Womens Ctr, Oxford OX3 9DU, England
关键词
abortion; medical; mifepristone; surgical; termination;
D O I
10.1093/humrep/16.1.67
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The aim of this retrospective study was to compare the efficacy and complications associated with early medical and surgical pregnancy termination. The study population comprised 932 consecutive women undergoing pregnancy termination at gestations of 63 days or less. There were no age or parity differences between the study groups. Medical termination was performed with mifepristone 200 mg orally and misoprostol 800 mug vaginally; surgical aspiration termination was performed under general anaesthesia. Outcome measures were: surgical curettage for presumed retained products of conception; ongoing pregnancy; and planned and emergency review in the unit. Early medical and surgical termination were associated with a 90.2 and 94.5% complete abortion rate respectively (P = 0.025). The complete abortion rate with medical termination decreased significantly with increasing parity; no such relationship with surgical abortion was found. Women of parity three or more were less likely to have a complete abortion following a medical (83.3%) compared to surgical procedure (97.7%) (P = 0.028), The ongoing pregnancy rate was 0.9% with medical and 0.5% with surgical termination (P NS). Medical termination was associated with a lower complete abortion rate than surgical termination, particularly for women of higher parity. However, early medical termination allows over 90% of women to avoid the risks of surgical instrumentation of the uterus and anaesthesia.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 16 条
[1]  
[Anonymous], 1993, BMJ, V307, P532
[2]   An effective regimen for early medical abortion: a report of 2000 consecutive cases [J].
Ashok, PW ;
Penney, GC ;
Flett, GMM ;
Templeton, A .
HUMAN REPRODUCTION, 1998, 13 (10) :2962-2965
[3]   Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh [J].
Cameron, ST ;
Glasier, AF ;
Logan, J ;
Benton, L ;
Baird, DT .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1996, 103 (12) :1222-1229
[4]   CERVICAL PRIMING WITH PROSTAGLANDIN-E1 ANALOGS, MISOPROSTOL AND GEMEPROST [J].
ELREFAEY, H ;
CALDER, L ;
WHEATLEY, DN ;
TEMPLETON, A .
LANCET, 1994, 343 (8907) :1207-1209
[5]   INDUCTION OF ABORTION WITH MIFEPRISTONE (RU-486) AND ORAL OR VAGINAL MISOPROSTOL [J].
ELREFAEY, H ;
RAJASEKAR, D ;
ABDALLA, M ;
CALDER, L ;
TEMPLETON, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (15) :983-987
[6]  
FERNER RE, 1996, PRESCRIBERS J, V36, P73
[7]  
HAKIMELAHI E, 1990, OBSTET GYNECOL, V76, P129
[8]   EARLY COMPLICATIONS AFTER INDUCED 1ST-TRIMESTER ABORTION [J].
HEISTERBERG, L ;
KRINGELBACH, M .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, 66 (03) :201-204
[9]   COMPARISON OF MEDICAL ABORTION WITH SURGICAL VACUUM ASPIRATION - WOMENS PREFERENCES AND ACCEPTABILITY OF TREATMENT [J].
HENSHAW, RC ;
NAJI, SA ;
RUSSELL, IT ;
TEMPLETON, AA .
BRITISH MEDICAL JOURNAL, 1993, 307 (6906) :714-717
[10]   THE EFFICACY OF ORAL MIFEPRISTONE (RU-38,486) WITH A PROSTAGLANDIN-E1 ANALOG VAGINAL PESSARY FOR THE TERMINATION OF EARLY-PREGNANCY - COMPLICATIONS AND PATIENT ACCEPTABILITY [J].
HILL, NCW ;
FERGUSON, J ;
MACKENZIE, IZ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 162 (02) :414-417